# What Parents Should Know About "Ozempic Feet" and GLP-1 Weight Loss Drugs
Doctors are reporting a new side effect linked to GLP-1 medications like Ozempic and Wegovy. The condition, nicknamed "Ozempic feet," involves changes to the feet and skin that occur as people lose weight rapidly on these diabetes and weight loss drugs.
GLP-1 receptor agonists work by slowing digestion and reducing appetite. They've become popular for weight management, but the rapid weight loss they produce can have unexpected physical consequences. When someone loses significant weight quickly, the skin and tissues in the feet can shift and change appearance. This includes sagging skin, altered fat distribution, and visible structural changes in the foot itself.
The condition isn't dangerous, but it can be cosmetically concerning for patients. Some people experience loose or wrinkled skin on their feet and around the ankle area. Others notice their feet look bony or aged beyond their years. The changes happen because the feet lose volume rapidly as overall body fat decreases.
Dermatologists and podiatrists explain that this occurs with any rapid weight loss, not just from GLP-1s. However, these medications produce faster results than traditional dieting, which makes the foot changes more noticeable. The skin doesn't always tighten back up immediately after weight stabilizes.
For parents whose teenagers or young adults are considering these medications for weight management, understanding potential side effects matters. While "Ozempic feet" isn't medically serious, it's worth discussing with doctors before starting treatment. The FDA has approved GLP-1s for certain weight conditions in teens, so conversations about expectations are important.
Most foot changes improve or stabilize once weight loss plateaus. Dermatological treatments like skin tightening procedures exist for those bothered by the appearance. Staying hyd